Prospective Trials in the U.S. Confirm Earlier Retrospective Studies Initiated by the Company HOUSTON, TX–May 28, 2009 — Power3 Clinical laboratory Products, Inc. (OTC BB:PWRM.OB ) announced today a significant breakthrough related to the diagnosis of patients wi…
Diagnostics, Neurology
Power3 Pharma Products, NuroPro, Alzheimer’s disease
Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.
To get the details: Click Here
0 Comments on “Power3 Clinical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer’s”
Leave a Comment